electronic health records ehr term paper
Excerpt via Term Paper:
The most common treatment for hemophilia is alternative therapy, in which concentrates of the clotting elements (factor VIII for hemophilia A or perhaps factor IX for hemophilia B) will be administered to the patient. Clotting factors can be acquired from treated human blood sources or perhaps recombinant sources. (NHLBI, in. d. ) Recombinant factors “are of inserting the DNA encoding the human protein into mammalian cells cultivated in culture. They are filtered and highly processed and are non-plasma derived items. ” (Hemophilia-Information, n. d. ) Many patients have replacement remedy on a prophylactic (preventive) basis daily, others apply treatment only in the event of a bleeding event/injury (NHLBI, n. deb. ). Other treatment options, commonly used for specific situations such as prior to teeth surgery or to treat active bleeding, contain:
Desmopressin (DDAVP), which is a man-made hormone that stimulates the release of kept factor VIII and vonWillebrand factor, whilst also increasing the level of these kinds of proteins in the blood stream, to get patients who may have mild to moderate hemophilia A. DDAVP is typically implemented via injection or sinus spray. (NHLBI, n. deb. )
Antifibrinolytic medicines (including tranexamic chemical p and aminocaproic acid), which might be used in combo with replacement unit therapy. These kinds of agents help keep blood clots from deteriorating once created, and are generally administered in pill type (NHLBI, n. d. )
Currently, you will discover treatments, since described over. However , experts are going after gene therapy approaches, which effect gives a cure. (Mannucci, 2003). For instance , this type of treatment is being receive claims from researchers in the U. S. And the British isles together with Netherlands-based Amsterdam Molecular Therapeutics, a business that specializes in gene disorders. The study uses as the key system a “vector-gene combination” that was first produced at St Jude Children’s Research Clinic in Memphis. Reportedly, “[t]this individual gene therapy used in the trial engages adeno-associated infections (AAV), tiny viruses which experts claim not trigger disease and produce mild immune responses, as vectors (delivery vehicles) to present a working factor IX (FIX) gene into the liver cells of subjects with hemophilia N. The goal of the trial should be to trigger viable, long-term FIX protein creation through a sole administration with the therapy. This could reduce or perhaps eliminate blood loss episodes in hemophilia N. patients. inch (Medical Information Today).
Recommendations
Hemophilia Inherited genes (n. deb. ). Gathered 13 04, 2010 in the Hemophilia-Information. com web site. http://www.hemophilia-information.com/hemophilia-genetics.html
Mannucci EVENING. (2003). Hemophilia: treatment options inside the twenty-first 100 years. J Thromb Haemost 1(7) pp. 1349-55.
Medical Information Today. (11 March 2010). Research Revise: Gene Therapy for Hemophilia B. Gets into New Expansion Phase. Recovered from the Nationwide Hemophilia Relationship Web site http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=118contentid=1490
NHLBI – National Heart, Lung and Blood Commence. (n. d. ). Just how is Hemophilia Treated. Retrieved 13 Apr 2010 coming from http://www.nhlbi.nih.gov/health/dci/Diseases/hemophilia/hemophilia_treatments.html
Peyvandi F; Jayandharan G; Chandy M; Srivastava A; Nakaya SM; Manley MJ; Thompson AR; Goodeve A; Garagiola I; Lavoretano S; Menegatti M; Globo R; Spreafico M; Tagliabue L; Asselta R; Duga S; Mannucci PM (2006). Genetic diagnosis of haemophilia and also other inherited bleeding disorders. Haemophilia 12, Suppl 3, pp. 82-9.
Schoenstadt, A. (2008). Causes of Hemophilia. eMedTV. Recovered from http://blood.emedtv.com/hemophilia/causes-of-hemophilia.html
